Nanotechnology Stock

Nano Global, Inc

On September 10, 2002, the Company entered into an Agreement and Plan of reorganization with MicroSignal Corporation, a Pennsylvania corporation, and exchanged 100% of the MicroSignal common stock in exchange for the issuance of 17,051,344 shares of the Company's common stock, or 94% of the Company. At that time, the Company changed its name to "MicroSignal Corporation". At the same time, the ... more

Nano Holdings Intl

Nano Jet Corp

Nanoforce, Inc.

Nanoscience Inc

Nanotech Fuel Corp.

Oryx Technology

Oryx Technology Corp. is the successor of Advanced Technology, Inc., which was incorporated on April 21, 1976 in New Jersey. On July 25, 1993, Advanced Technology formed Oryx as a wholly-owned Delaware subsidiary, and on September 29, 1993, Advanced Technology merged with and into Oryx Technology Corp. References to "Oryx," "we," "our" and "us" refer to Oryx Technology Corp. ... more

Photon Technology International, Inc.

Photon Technology International, Inc. (the "Company" or "PTI(R)") is a New Jersey based high technology corporation, incorporated in November 1983. PTI is engaged in the business of exploiting the many applications of the proprietary fluorescence technology that it has developed. more

Precision Optics Cp

Precision Optics Corporation, Inc. (the “Company”) was incorporated in Massachusetts in 1982 and has been publicly owned since November 1990. References to the Company contained herein include its two wholly-owned subsidiaries, except where the context otherwise requires. more

Strategy International Insrnc Grp, Inc

Strategy International Insurance Group, Inc., a Texas corporation (referred to in this annual report as “we”, “us”, “our”, “Strategy International”, the “Company” or “our company”) is a publicly traded holding company for a group of financial service companies that are located throughout the ... more

Sysview Technology

" in this Annual Report on Form 10-KSB are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by forward-looking statements. more

Verex Laboratories, Inc.

On or about March 31, 2000, PR Pharmaceuticals, Inc. ("PRP"), a privately held pharmaceuticals company focused on developing drug delivery systems, acquired 52.95% of the outstanding common stock of the Company from certain of the shareholders and directors of the Company. The selling shareholders received one share of PRP common stock for each 15 shares of Verex common stock. PRP agreed to ... more

previous 5 6 7 8 9 10 11 total items: 162